These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22209086)

  • 1. Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral reflux.
    Arlen AM; Pakalniskis BL; Cooper CS
    J Pediatr Urol; 2012 Jun; 8(3):e27-30. PubMed ID: 22209086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Obstruction With Asymptomatic Loss of Renal Function After Dextranomer/Hyaluronic Acid Copolymer (Deflux) Injection for Vesicoureteral Reflux: A Close Look at a Disturbing Outcome.
    Papagiannopoulos D; Rosoklija I; Cheng E; Yerkes E
    Urology; 2017 Mar; 101():63-66. PubMed ID: 27687330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed onset ureteral obstruction following Deflux® injection for vesicoureteral reflux.
    Zemple RP; Potretzke AM; Kryger JV
    J Pediatr Urol; 2012 Jun; 8(3):e23-6. PubMed ID: 22257585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer.
    Nseyo U; Mancini JG; Wiener JS
    Urology; 2013 Jan; 81(1):184-7. PubMed ID: 23200968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
    Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
    J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series.
    Rubenwolf PC; Ebert AK; Ruemmele P; Rösch WH
    Urology; 2013 Mar; 81(3):659-62. PubMed ID: 23452811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ureteral obstruction after dextranomer/hyaluronic acid copolymer injection for treatment of secondary vesicoureteral reflux after renal transplantation.
    Seifert HH; Mazzola B; Zellweger T; Ruszat R; Muller A; Burkhalter F; Steiger J; Sulser T; Bachmann A
    Urology; 2006 Jul; 68(1):203.e17-9. PubMed ID: 16808962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (deflux) injection for treatment of vesicoureteral reflux in children: a case series.
    Canning DA
    J Urol; 2014 May; 191(5):1409. PubMed ID: 24745538
    [No Abstract]   [Full Text] [Related]  

  • 9. Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer.
    Snodgrass WT
    J Urol; 2004 Jan; 171(1):395-6. PubMed ID: 14665941
    [No Abstract]   [Full Text] [Related]  

  • 10. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success.
    Lavelle MT; Conlin MJ; Skoog SJ
    Urology; 2005 Mar; 65(3):564-7. PubMed ID: 15780377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R; Vandersteen D
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A CASE OF DEXTRANOMER-HYALURONIC ACID COPOLYMER (Deflux
    Matsumoto F; Matsui F; Yazawa K; Shimada K
    Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):49-51. PubMed ID: 29367510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distal and late ureteral obstruction: a rare complication following dextranomer/hyaluronic acid injection for vesicoureteral reflux in children].
    Abbo O; Bouali O; Beauval JB; Moscovici J; Galinier P
    Prog Urol; 2012 Mar; 22(3):192-4. PubMed ID: 22364632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM; Peele PB; Docimo SG
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
    Stenberg A; Larsson E; Läckgren G
    J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed-onset Ureteral Obstruction and Calcification Masquerading as Renal Colic Following Deflux Injection.
    Romain J; Fourcade L; Centi J; Blanc P; Masselin MC; Lescure V; Guigonis V; Descazeaud A; Ballouhey Q
    Urology; 2016 Aug; 94():218-20. PubMed ID: 26970448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
    Chertin B; Mele E; Kocherov S; Zilber S; Gerocarni Nappo S; Capozza N
    J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.